Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Principal Investigator
Name
Pinchas Akiva
Degrees
PhD
Institution
Medial-Research
Position Title
Bioinformatics Senior Scientist
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-103
Initial CDAS Request Approval
Aug 26, 2014
Title
Development of a personalized lung cancer risk prediction model
Summary
Reducing the number of individuals needed to screen in order to prevent lung cancer mortality is a challenge. The purpose of this study is to develop and validate a lung cancer risk prediction model for identifying individuals at high risk of having lung cancer. The model should aid optimizing the selection criteria of individuals to be screened for lung cancer, helping to increase the positive predictive value of lung cancer screening.

In the development process, we will utilize machine learning based algorithmic tools (such as decision tree algorithms) that analyze the characteristics of lung cancer patients, and produce a model that enables defining the probability of a specific individual to harbor lung cancer. The model will take into account smoking behavior as well as other data types such as demographics and disease history.

To increase the validity of the results, the study datasets will include the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) and the National Lung Screening Trial (NLST) datasets.
Aims

Develop a model that generates an individual risk score to enable identifying individuals at high risk for having lung cancer.